Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis

Published:2013-06-14 Issue:6 Volume:8 Page:e66164
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ness Daniel,Ren Zhao,Gardai Shyra,Sharpnack Douglas,Johnson Victor J.,Brennan Richard J.,Brigham Elizabeth F.,Olaharski Andrew J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Parkinson’s disease;AJ Lees;Lancet,2009

2. Revelations and revolutions in the understanding of Parkinson’s disease;TM Dawson;Biochim Biophys Acta,2009

3. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology;A Zimprich;Neuron,2004

4. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease;C Paisan-Ruiz;Neuron,2004

5. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease;MR Cookson;Nat Rev Neurosci,2010

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIGAR exacerbates obesity by triggering LRRK2-mediated defects in macroautophagy and chaperone-mediated autophagy in adipocytes;Autophagy;2024-04-30

2. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage;npj Parkinson's Disease;2024-03-01

3. Astrocytic LRRK2 Controls Synaptic Connectivity through ERM Phosphorylation;2023-04-10

4. LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease;Movement Disorders;2023-02-18

5. The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson’s Disease;Journal of Medicinal Chemistry;2023-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3